Dr. Bartlett is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
660 S Euclid Ave
Saint Louis, MO 63110
Education & Training
Washington University in St. Louis School of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1988 - Present
MO State Medical License 1993 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Autologous Stem Cell Transplant-Eligible Patients With Relapsed/Refractory Aggressive B Cell Lymphoma Start of enrollment: 2023 Jan 03
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial.Amitkumar Mehta, Leslie Popplewell, Graham P Collins, Sonali M Smith, Ian W Flinn
Blood Advances. 2024-11-26 - 1 citationsTocilizumab Prophylaxis Following Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma.Frederick L Locke, Sattva S Neelapu, Nancy L Bartlett, Lazaros J Lekakis, Caron A Jacobson
Transplantation and Cellular Therapy. 2024-11-01 - Bispecific antibodies in follicular lymphoma.Imran A Nizamuddin, Nancy L Bartlett
Haematologica. 2024-10-31
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
